Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Dia-Präsentation von Merck Gesellschaft mbH.
Micardis(R) - Micardis Plus(R) - Klinische Wirksamkeit (39 Abbildungen)
Übersicht


Zum ersten Bild Abb. 15: Telmisartan - Valsartan Abb. 16: Telmisartan - Ramipril Abb. 17: Telmisartan - Ramipril Aktuelles Bild - Abb. 18: Morgendlicher Blutdruckanstieg Abb. 19: Telmisartan - Perindopril Abb. 20: Telmisartan - Perindopril Abb. 21: Telmisartan - Enalapril Zum letzten Bild
Abbildung 18: Morgendlicher Blutdruckanstieg
Patients with a high EMBPS have been shown to be at increased risk of stroke.1 In the study that demonstrated this connection, the EMBPS was defined as the difference between the early morning mean (the average blood pressure in the first 2 hours after waking) and the night-time low (the average of three blood pressure readings centred on the lowest night-time reading).1 These definitions were used to calculate the EMBPS of patients in two studies of identical design that compared telmisartan 80 mg with ramipril 10 mg (PRISMA I and II).2 The 25% of patients with the highest EMBPS of DBP all had an EMBPS ≥35 mmHg.2 In these patients, telmisartan reduced the magnitude of the EMBPS by a significantly greater amount than did ramipril.2 1. Kario K, et al. Morning surge in BP as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives. Circulation 2003; 107: 1401–1406. 2. Data on file. Boehringer Ingelheim GmbH.
 
Morgendlicher Blutdruckanstieg
Vorheriges Bild Nächstes Bild   


Abbildung 18: Morgendlicher Blutdruckanstieg
Patients with a high EMBPS have been shown to be at increased risk of stroke.1 In the study that demonstrated this connection, the EMBPS was defined as the difference between the early morning mean (the average blood pressure in the first 2 hours after waking) and the night-time low (the average of three blood pressure readings centred on the lowest night-time reading).1 These definitions were used to calculate the EMBPS of patients in two studies of identical design that compared telmisartan 80 mg with ramipril 10 mg (PRISMA I and II).2 The 25% of patients with the highest EMBPS of DBP all had an EMBPS ≥35 mmHg.2 In these patients, telmisartan reduced the magnitude of the EMBPS by a significantly greater amount than did ramipril.2 1. Kario K, et al. Morning surge in BP as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives. Circulation 2003; 107: 1401–1406. 2. Data on file. Boehringer Ingelheim GmbH.
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung